Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dickstein

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Circulation|February 1, 1995
Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study GroupI Crozier, H Ikram, N Awan, et al.
British Journal of Clinical Pharmacology|April 1, 1987
The pharmacokinetics of enalapril in hospitalized patients with congestive heart failureK Dickstein, A E Till, T Aarsland, et al.
Journal of Cardiac Failure|July 15, 1999
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE IIB Pitt, P Poole-Wilson, R Segal, et al.
Lancet (London, England)|May 23, 2000
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE IIB Pitt, P A Poole-Wilson, R Segal, et al.
European Heart Journal|February 25, 2005
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityK Malmberg, L Rydén, H Wedel, et al.
European Heart Journal|March 23, 2017
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European studyW Ouwerkerk, A A Voors, S D Anker, et al.
European Heart Journal|December 15, 2018
Novel endotypes in heart failure: effects on guideline-directed medical therapyJ Tromp, W Ouwerkerk, B G Demissei, et al.
Journal of Internal Medicine|May 7, 2020
Tumour biomarkers: association with heart failure outcomesC Shi, H H van der Wal, H H W Silljé, et al.
International Journal of Cardiology|May 1, 2014
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensusM S Nieminen, J Altenberger, T Ben-Gal, et al.
The New England Journal of Medicine|July 8, 2011
Effect of nesiritide in patients with acute decompensated heart failureC M O'Connor, R C Starling, A F Hernandez, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Circulation|February 1, 1995
Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study GroupI Crozier, H Ikram, N Awan, et al.
British Journal of Clinical Pharmacology|April 1, 1987
The pharmacokinetics of enalapril in hospitalized patients with congestive heart failureK Dickstein, A E Till, T Aarsland, et al.
Journal of Cardiac Failure|July 15, 1999
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE IIB Pitt, P Poole-Wilson, R Segal, et al.
Lancet (London, England)|May 23, 2000
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE IIB Pitt, P A Poole-Wilson, R Segal, et al.
European Heart Journal|February 25, 2005
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityK Malmberg, L Rydén, H Wedel, et al.
European Heart Journal|March 23, 2017
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European studyW Ouwerkerk, A A Voors, S D Anker, et al.
European Heart Journal|December 15, 2018
Novel endotypes in heart failure: effects on guideline-directed medical therapyJ Tromp, W Ouwerkerk, B G Demissei, et al.
Journal of Internal Medicine|May 7, 2020
Tumour biomarkers: association with heart failure outcomesC Shi, H H van der Wal, H H W Silljé, et al.
International Journal of Cardiology|May 1, 2014
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensusM S Nieminen, J Altenberger, T Ben-Gal, et al.
The New England Journal of Medicine|July 8, 2011
Effect of nesiritide in patients with acute decompensated heart failureC M O'Connor, R C Starling, A F Hernandez, et al.
Pageof 11